triamcinolone acetonide has been researched along with Autoimmune Diabetes in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (82.35) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beredjiklian, PK; Hoffler, CE; Kim, N; Lutsky, KF; Matzon, JL; Schroeder, J | 1 |
| Jonas, J; Rensch, F | 1 |
| Gillies, M | 1 |
| Blanco-Garavito, R; Rodriguez-Valdes, PJ | 1 |
| Kim, SJ | 1 |
| Agarwal, M; Chaudhary, SP; Narula, R; Shroff, C | 1 |
| Aiello, LP; Beck, RW; Bressler, NM; Bressler, SB; Edwards, AR; Elman, MJ; Ferris, FL; Friedman, SM; Glassman, AR; Miller, KM; Scott, IU; Stockdale, CR; Sun, JK | 1 |
| Baek, GH; Gong, HS; Lee, SY; Noh, JH; Oh, JH; Roh, YH; Yi, SR | 1 |
| Fauser, S; Joussen, AM; Kirchhof, B; Krohne, TU | 1 |
| Lang, GE | 1 |
| Avci, R; Kaderli, B | 1 |
| Angerman, S; Kytö, JP; Lumiste, E; Paloheimo, M; Summanen, PA | 1 |
| Bandello, F; Dimastrogiovanni, A; Monaco, P; Paissios, J; Pognuz, DR; Polito, A | 1 |
| Audren, F; Benosman, R; Bergmann, JF; Erginay, A; Gaudric, A; Haouchine, B; Lecleire-Collet, A; Massin, P | 1 |
| Aiello, LP; Antoszyk, A; Beck, R; Bressler, N; Browning, D; Chew, E; Danis, R; Fan, J; Flaxel, C; Friedman, S; Glassman, A; Kollman, C; Lazarus, H; Strauber, S | 1 |
| Chibani, A; Feldman-Billard, S; Héron, E | 1 |
2 review(s) available for triamcinolone acetonide and Autoimmune Diabetes
| Article | Year |
|---|---|
[Diabetic maculopathy - classification and therapy].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Humans; Injections; Laser Coagulation; Macular Edema; Triamcinolone Acetonide; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2003 |
[Pharmacological treatment of diabetic retinopathy].
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Humans; Injections; Macular Edema; Multicenter Studies as Topic; Octreotide; Prospective Studies; Protein Kinase C; Somatostatin; Triamcinolone Acetonide; Vitreous Body | 2004 |
7 trial(s) available for triamcinolone acetonide and Autoimmune Diabetes
| Article | Year |
|---|---|
Elevated Hemoglobin A1C Levels Correlate with Blood Glucose Elevation in Diabetic Patients following Local Corticosteroid Injection in the Hand: A Prospective Study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Carpal Tunnel Syndrome; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucocorticoids; Glycated Hemoglobin; Hand; Humans; Hyperglycemia; Injections; Male; Middle Aged; Prospective Studies; Tendinopathy; Triamcinolone Acetonide | 2015 |
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Topics: Aged; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Ranibizumab; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Intra-articular corticosteroid injection in diabetic patients with adhesive capsulitis: a randomized controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bursitis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Male; Middle Aged; Pain Measurement; Range of Motion, Articular; Recovery of Function; Shoulder Joint; Treatment Outcome; Triamcinolone Acetonide | 2012 |
Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Topics: Adult; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Male; Middle Aged; Prospective Studies; Retinal Neovascularization; Triamcinolone Acetonide; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macula Lutea; Macular Edema; Middle Aged; Prospective Studies; Recurrence; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2006 |
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Orbit; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
8 other study(ies) available for triamcinolone acetonide and Autoimmune Diabetes
| Article | Year |
|---|---|
Diabetic macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Diabetic macular edema.
Topics: Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
DRCR Study: outcomes in focal vs diffuse edema?
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Diabetic macular edema.
Topics: Cataract; Cataract Extraction; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Randomized Controlled Trials as Topic; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Diabetic macular edema.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Preservatives, Pharmaceutical; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Exudates and Transudates; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up.
Topics: Adult; Anesthesia, Local; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone and blood glucose.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Injections; Macular Edema; Middle Aged; Retinal Detachment; Triamcinolone Acetonide; Vitrectomy; Vitreous Body; Vitreous Hemorrhage | 2008 |